Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2027 studies found for:    serotonin reuptake inhibitor
Show Display Options
Rank Status Study
1 Completed Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Condition: Local Anesthesia
Intervention: Drug: selective serotonin reuptake inhibitor
2 Completed CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
Conditions: Depression;   Epilepsy, Temporal Lobe
Interventions: Other: Cognitive behavioral therapy;   Drug: SSRI
3 Completed Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
Condition: Overactive Bladder
Interventions: Drug: Selective serotonin reuptake inhibitors;   Drug: Antimuscarinics
4 Completed The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
Conditions: Gastric Bypass;   Depression;   Anxiety Disorder
Intervention: Procedure: Roux-en-Y gastric bypass (RYGBP)
5 Completed Do Serotonin Reuptake Inhibitors (SSRIs) Affect Bone Mass in Adolescents
Condition: The Skeletal Effects of SSRIs
6 Unknown  Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors
Condition: Tracheostomy Complication
7 Completed
Has Results
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
Condition: Depressive Disorder
Interventions: Drug: 323U66 (Bupropion Hydrochloride Sustained Release);   Drug: Placebo
8 Completed Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine fumarate (Seroquel)
9 Completed A Study in Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
10 Unknown  A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: bitopertin;   Drug: placebo
11 Completed A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
12 Completed A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: LY2216684;   Drug: Placebo
13 Not yet recruiting Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors
Conditions: Ssri;   Neuronal Plasticity
Interventions: Drug: Escitalopram;   Drug: Placebo;   Other: 3xMR scan (fMRI, DTI, strucutral MRI);   Behavioral: Association learning paradigm;   Behavioral: Association re-learning paradigm
14 Completed
Has Results
Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression
Condition: Depression
Interventions: Drug: S-adenosyl methione (SAMe);   Drug: Placebo
15 Recruiting The Gut Microbiota in Obsessive-Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Intervention: Drug: SSRIs
16 Recruiting Effect of Antenatal SSRI Exposure on the QT Interval of Neonates
Conditions: Qt Interval, Variation in;   Adverse Effect of Selective Serotonin Reuptake Inhibitors
Intervention: Procedure: Electrocardiogram
17 Recruiting A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
Condition: Obsessive-Compulsive Disorder
Interventions: Drug: pregabalin;   Drug: Placebo
18 Completed The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults
Condition: Depression
Intervention: Drug: Sertraline
19 Terminated
Has Results
Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
Conditions: Patient Diagnosed With OCD and Resistant to SSRI Treatment;   Failed SSRI Over 12 Weeks at Appropriate Doses
Interventions: Drug: AFQ056;   Drug: Placebo
20 Terminated Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes
Condition: Depression

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.